Glomerular Filtration Rate Changes in Neonates with Sepsis Treated with Amikacin and Cefotaxime

 Background and purpose: Aminoglycosides (AG) such as Amikacin that are widely used to prevent and treat infections in neonates have nephrotoxic effects. The aim of this study was to evaluate the role of urinary index to Glomerular filtration rate (GFR) in diagnosis of tubular renal injury following administration of Amikacin in neonates admitted to neonatal intensive care unit (NICU). Materials and methods: In this descriptive cross-sectional study, 45 neonates admitted to NICU with confirmed sepsis undergone treatment with Amikacin and Ampicillin and 45 neonates were treated with Ampicillin and Cefotaxime. GFR was calculated using Schwartz's formula (serum creatinine/height * 0.45) and categorized based on Fanaroff table. In both groups, BUN, Cr, and GFR were measured at days one and seven. Data analysis was performed in SPSS. Results: Two (4.4%) patients in the group treated with Amikacin and Ampicillin and one (2.2%) in the group who received Ampicillin and Cefotaxime developed acute kidney injury (AKI). GFR changes and Cr levels at day seven were not found to be significantly different between septic neonates treated with Amikacin and Ampicillin and neonates treated with other non-aminoglycosidic antibiotics (P>0.05). Conclusion: There was no difference in incidence of AKI between neonates receiving Amikacin and Ampicillin and those who received Ampicillin and Cefotaxime. Hence, AKI in these neonates requires further evaluations.